GT200200184A - Formulaciones farmaceuticas - Google Patents
Formulaciones farmaceuticasInfo
- Publication number
- GT200200184A GT200200184A GT200200184A GT200200184A GT200200184A GT 200200184 A GT200200184 A GT 200200184A GT 200200184 A GT200200184 A GT 200200184A GT 200200184 A GT200200184 A GT 200200184A GT 200200184 A GT200200184 A GT 200200184A
- Authority
- GT
- Guatemala
- Prior art keywords
- prospected
- release
- pharmaceutical formulations
- synthrics
- hypropressive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
Abstract
LA PRESENTE INVENCION SE REFIERE A FORMULACIONES FARMACEUTICAS ORALES DE LIBERACION CONTROLADA DE COMPUESTOS ANTAGONISTAS DE RECEPTORES ALFAADRENERGICOS QUE INCLUYEN A LA 4AMINO6,7DIMETOXI2(5METANOSULFONAMIDO1,2,3,4TETRAHIDROISOQUINOL2IL)5(2PIRIDIL) QUINAZOLINA Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. EL OBJETO DE LA SOLICITUD ES EL DE MODIFICAR LA VELOCIDAD DE LIBERACION DEL FARMACO PARA PRODUCIR UNA LIBERACION CONSTANTE EN EL TRACTO GASTROINTESTINAL EN EL QUE EL PRINCIPIO ACTIVO ES DE UTILIDAD EN CASOS DE HIPERTENSION, INSUFICIENCIA CARDIACA CONGESTIVA, HIPERPLASIA PROSTATICA BENIGNA, ENTRE OTROS DESCRITOS EN EL EXPEDIENTE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0124455.7A GB0124455D0 (en) | 2001-10-11 | 2001-10-11 | Pharmaceutical formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200200184A true GT200200184A (es) | 2003-05-23 |
Family
ID=9923660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200200184A GT200200184A (es) | 2001-10-11 | 2002-09-17 | Formulaciones farmaceuticas |
Country Status (32)
Country | Link |
---|---|
EP (1) | EP1434570B8 (es) |
JP (1) | JP4131471B2 (es) |
KR (1) | KR20050032510A (es) |
CN (1) | CN1568180A (es) |
AP (1) | AP2004003001A0 (es) |
AR (1) | AR036782A1 (es) |
AT (1) | ATE303135T1 (es) |
BR (1) | BR0213196A (es) |
CA (1) | CA2461168A1 (es) |
CO (1) | CO5560534A2 (es) |
DE (1) | DE60205925T2 (es) |
DK (1) | DK1434570T3 (es) |
DO (1) | DOP2002000464A (es) |
EA (1) | EA006168B1 (es) |
ES (1) | ES2246017T3 (es) |
GB (1) | GB0124455D0 (es) |
GT (1) | GT200200184A (es) |
HR (1) | HRP20040261A2 (es) |
HU (1) | HUP0600064A3 (es) |
IL (1) | IL160969A0 (es) |
IS (1) | IS7179A (es) |
MA (1) | MA27075A1 (es) |
MX (1) | MXPA04003293A (es) |
NO (1) | NO20041520L (es) |
OA (1) | OA12709A (es) |
PA (1) | PA8556001A1 (es) |
PE (1) | PE20030551A1 (es) |
PL (1) | PL369666A1 (es) |
SV (1) | SV2004001279A (es) |
UY (1) | UY27477A1 (es) |
WO (1) | WO2003032956A1 (es) |
ZA (1) | ZA200401976B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0317663D0 (en) * | 2003-07-29 | 2003-09-03 | Astrazeneca Ab | Pharmaceutical composition |
CA2902646C (en) | 2013-03-14 | 2022-08-16 | Cytokinetics, Inc. | Heterocyclic compounds and their uses |
KR101943592B1 (ko) | 2017-08-31 | 2019-01-30 | 조현우 | 데이터 마이닝 기법을 이용한 전자가계부 시스템 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE104826T1 (de) * | 1990-07-02 | 1994-05-15 | Bend Res Inc | Asymmetrische mikroporoese kuegelchen fuer regulierbare freigabe. |
FR2752737B1 (fr) * | 1996-08-29 | 1998-10-02 | Synthelabo | Comprime a liberation controlee de chlorhydrate d'alfuzosine |
GB9700504D0 (en) * | 1997-01-11 | 1997-02-26 | Pfizer Ltd | Pharmaceutical compounds |
IL141235A (en) * | 2000-02-09 | 2012-04-30 | Novartis Int Pharm Ltd | Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia |
KR100496089B1 (ko) * | 2000-03-03 | 2005-06-17 | 화이자 인코포레이티드 | 4-아미노-6,7-디메톡시-2-(5-메탄설폰아미도-1,2,3,4-테트라하이드로이소퀴놀-2-일)-5-(2-피리딜)퀴나졸린 메실레이트및 다형체 |
-
2001
- 2001-10-11 GB GBGB0124455.7A patent/GB0124455D0/en not_active Ceased
-
2002
- 2002-09-12 DO DO2002000464A patent/DOP2002000464A/es unknown
- 2002-09-17 GT GT200200184A patent/GT200200184A/es unknown
- 2002-09-30 JP JP2003535760A patent/JP4131471B2/ja not_active Expired - Fee Related
- 2002-09-30 DK DK02775048T patent/DK1434570T3/da active
- 2002-09-30 DE DE60205925T patent/DE60205925T2/de not_active Expired - Lifetime
- 2002-09-30 ES ES02775048T patent/ES2246017T3/es not_active Expired - Lifetime
- 2002-09-30 CA CA002461168A patent/CA2461168A1/en not_active Abandoned
- 2002-09-30 CN CNA02820042XA patent/CN1568180A/zh active Pending
- 2002-09-30 BR BR0213196-0A patent/BR0213196A/pt not_active IP Right Cessation
- 2002-09-30 KR KR1020047005316A patent/KR20050032510A/ko not_active Application Discontinuation
- 2002-09-30 MX MXPA04003293A patent/MXPA04003293A/es active IP Right Grant
- 2002-09-30 EP EP02775048A patent/EP1434570B8/en not_active Expired - Lifetime
- 2002-09-30 AT AT02775048T patent/ATE303135T1/de not_active IP Right Cessation
- 2002-09-30 IL IL16096902A patent/IL160969A0/xx unknown
- 2002-09-30 HU HU0600064A patent/HUP0600064A3/hu unknown
- 2002-09-30 OA OA1200400094A patent/OA12709A/en unknown
- 2002-09-30 WO PCT/IB2002/004040 patent/WO2003032956A1/en active IP Right Grant
- 2002-09-30 EA EA200400431A patent/EA006168B1/ru not_active IP Right Cessation
- 2002-09-30 PL PL02369666A patent/PL369666A1/xx not_active Application Discontinuation
- 2002-09-30 AP APAP/P/2004/003001A patent/AP2004003001A0/en unknown
- 2002-10-09 UY UY27477A patent/UY27477A1/es not_active Application Discontinuation
- 2002-10-09 PE PE2002000996A patent/PE20030551A1/es not_active Application Discontinuation
- 2002-10-09 AR ARP020103805A patent/AR036782A1/es unknown
- 2002-10-10 SV SV2002001279A patent/SV2004001279A/es not_active Application Discontinuation
- 2002-10-10 PA PA20028556001A patent/PA8556001A1/es unknown
-
2004
- 2004-03-11 IS IS7179A patent/IS7179A/is unknown
- 2004-03-11 ZA ZA200401976A patent/ZA200401976B/en unknown
- 2004-03-17 HR HR20040261A patent/HRP20040261A2/hr not_active Application Discontinuation
- 2004-03-18 CO CO04025929A patent/CO5560534A2/es not_active Application Discontinuation
- 2004-04-05 NO NO20041520A patent/NO20041520L/no unknown
- 2004-04-08 MA MA27623A patent/MA27075A1/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005531516A5 (es) | ||
AR054445A1 (es) | Formulaciones de un inhibidor de src/abl | |
EA200601160A1 (ru) | 2,6-бисгетероарил-4-аминопиримидины в качестве антагонистов аденозиновых рецепторов | |
JP2004501930A5 (es) | ||
NO20082988L (no) | Vedvarende frigivningsformulering innbefattende oktreotid og to eller flere polylaktid-ko-glykolidpolymerer | |
DE60232496D1 (de) | Tabletten, die in der mundhöhle schnell zerfallen | |
CO5580767A2 (es) | Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas y procedimientos para su uso | |
DE602004008098D1 (de) | Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren | |
CL2007001918A1 (es) | Compuestos derivados heteroarilos sustituidos; metodo para la preparacion de los compuestos; composicion farmaceutica; y uso para el tratamiento del dolor, depresion, enfermedad de alzheimer e hipertension entre otras. | |
ECSP055568A (es) | Composición de comprimido de liberación sostenida de pramipexol | |
MA27040A1 (fr) | Nucleosides substitues en 4' | |
DE60332629D1 (de) | Phenyl-(4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yi)aminderivate | |
ME00325B (me) | Oblik za oralnu primjenu etilestra 3-[(2-{[4-(heksiloksikarbonjlaminoimino-metil)-fenilamino]-metil}-1-metil-ih-benzimidazol-5-carbonil)-piridin- 2-yl-amino]-propionsk kisjeline i njihovih soli | |
DK1723144T3 (da) | Yderligere heteropolycykliske forbindelser og anvendelse deraf som metabotropiske glutamareceptor-antagonister | |
LU91867I2 (fr) | Fingolimod et ses dérivés pharmaceutiquement acceptables (GILENYA®) | |
GEP20053675B (en) | Pyridazinone Aldose Reductase Inhibitors | |
CY1114803T1 (el) | Παραγωγα πυριμιδινο σουλφοναμιδιου ως ρυθμιστες υποδοχεων χημειοκινης | |
ATE397605T1 (de) | Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol | |
MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
CY1105479T1 (el) | Παραγωγα τετραζολιου και μεθοδοι αντιμετωπισης σχετιζομενων με τον μεταβολισμο διαταραχων με αυτα | |
ATE516016T1 (de) | Selbstemulgierende formulierungen von cetp- hemmern | |
ATE384058T1 (de) | Thiazolderivate | |
ATE424821T1 (de) | Pyrrolopyridin-2-karbonsäureamide | |
ATE523498T1 (de) | Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate | |
UY27979A1 (es) | Indoles sustituidos en posición 2,4 |